What is it about?

The beneficial and adverse effects of pharmacological treatments of sleep-wake disorders are often variable and in part genetically determined. This overview discusses the currently known impact of genetic variants affecting exposure of and sensitivity to drugs targeting the neurochemistry of sleep-wake regulation and the pathophysiology of sleep-wake disturbances and their possible relevance for precision sleep-wake medicine.

Featured Image

Why is it important?

Sleep pharmacogenetics provides a powerful new tool to elucidate molecular mechanisms of sleep-wake regulation in humans, to understand inter-individual differences in safety and efficacy of sleep-wake therapies, and to develop possible novel treatment options for sleep-wake disorders which are highly prevalent in our (aging) society.

Read the Original

This page is a summary of: Sleep Pharmacogenetics: Personalized Sleep-Wake Therapy, The Annual Review of Pharmacology and Toxicology, January 2016, Annual Reviews,
DOI: 10.1146/annurev-pharmtox-010715-103801.
You can read the full text:

Read

Contributors

The following have contributed to this page